EX-10.5



 Exhibit 10.5 

 
 



 
 April 3, 2012 
 Mr. David R. Crockford 
 62 Kent Street 

Newburyport, MA 01950 
  

	Re:	Temporary Employment Terms 

 Dear David:

 Due to the Company’s current financial situation, it is necessary for the Company to reduce its labor costs. Accordingly, the Company is
reducing all salaries and work hours. You are being offered the opportunity to continue your employment with RegeneRx Biopharmaceuticals, Inc. (the “Company”) at its Rockville, Maryland location as part-time, temporary
employee. Your position will remain as Vice President, Clinical and Regulatory Affairs, performing such duties as are normally associated with this position and such duties as are assigned to you from time to time. Commencing on April 1, 2012,
will receive a salary at a rate of $96.01 per hour for work related to the May 2010 grant from the National Institutes of Health’s National Heart Lung & Blood Institute (the “NIH Grant”), and at a rate of $50.00 per hour for
all other work. Such payments will be subject to payroll deductions and all required withholdings and payable in accordance with the Company’s standard payroll practices. 
 Your typical work schedule will be up to 20 hours per month for non-grant activities; however, you will be scheduled according to the Company’s needs, and the Company does not guarantee you any
minimum number of hours of work per month. You may be asked to work additional hours; however, you should not work beyond your scheduled work hours for the month unless J.J. Finkelstein has expressly requested you to do so or you have received the
written approval of J.J. Finkelstein prior to working the additional time. If you work beyond your scheduled work hours without permission, you will be subject to disciplinary action up to and including termination. You must record your hours worked
on a daily basis, including your start and stop times, and meal periods. 
 You will not be eligible for any Company benefits, including but not
limited to: health coverage, holidays, paid vacation, sick leave, and other insurance coverage. You will be eligible for certain minimum benefits required by law, such as workers’ compensation, unemployment, and Social Security. 

You acknowledge your continuing obligations under your Proprietary Information, Non-Competition and Inventions Assignment Agreement dated
November 4, 2005, which remains in full force and effect. Additionally, your employment continues to be subject to the Company’s personnel policies and procedures as they may be interpreted, adopted, revised or deleted from time to time in
the Company’s sole discretion. 

  
 RegeneRx
Biopharmaceuticals, Inc. — 15245 Shady Grove Road, Suite 470, Rockville, MD 20850 
 PHONE 301.208.9191 — FAX 301.208.9194 — WEB www.regenerx.com 








 Your employment with the Company is temporary. The Company anticipates that your employment will continue
until June 30, 2012, which will be your employment termination date unless your employment is terminated earlier by you or by the Company. Continued work beyond June 30, 2012, does not automatically convert your employment to regular
status. 
 Your employment relationship with the Company will continue to be at-will. You may terminate your employment with the Company at any
time and for any reason whatsoever simply by notifying the Company. Likewise, the Company may terminate your employment at any time, with or without cause or advance notice. Your employment at-will status can only be modified in a written agreement
signed by you and by an officer of the Company. 
 By signing this letter, you acknowledge that the terms described in this letter, together
with the your Proprietary Information, Non-Competition and Inventions Assignment Agreement, set forth the entire understanding between us and supersede any other representations or agreements, whether written or oral, including, but not limited to
your Second Amended and Restated Employment Agreement dated March 31, 2009, as amended; there are no terms, conditions, representations, warranties or covenants other than those contained herein. No term or provision of this letter may be
amended waived, released, discharged or modified except in writing, signed by you and an authorized officer of the Company, except that the Company may, in its sole discretion, adjust salaries, incentive compensation, stock plans, benefits, job
titles, locations, duties, responsibilities, and reporting relationships. 
 Please indicate your acceptance of this offer by signing below and
returning it to me. 
 Sincerely, 
  

	
	 /s/ J.J. Finkelstein

	J.J. Finkelstein
	President and Chief Executive Officer
	
	ACCEPTED AND AGREED TO:
	
	 /s/ David R.
Crockford            

	David Crockford
	
	April 3, 2012
	Date